deltatrials
Completed NA INTERVENTIONAL 3-arm NCT00410852

Efficacy and Safety of Three Insulin Protocols in Medical Intensive Care Unit Patients

Randomized Study to Evaluate the Efficacy and Safety of Two Endovenous Insulin Protocols and a Subcutaneous Insulin Protocol in Critically Ill Patients

Sponsor: Fundação de Amparo à Pesquisa do Estado de São Paulo

Conditions Intensive Care
Interventions Computer-assisted IV insulin infusion protocol (algorithm A) Conventional Intermittent Insulin Protocol (Algorithm C) Leuven Strict glycemic control protocol (Algorithm B)
Updated 6 times since 2017 Last updated: Oct 31, 2007 Started: May 31, 2005 Completion: Mar 31, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00410852, this NA trial focuses on Intensive Care and remains completed. Sponsored by Fundação de Amparo à Pesquisa do Estado de São Paulo, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Hospital Israelita Albert Einstein
Data source: Hospital Israelita Albert Einstein

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations